IMJUDO 300MG/15ML INJECTION

by ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV) · 1 VIAL · Prescription required

Price: ₹354894.24 (MRP ₹417522.64) · In stock

IMJUDO 300MG/15ML INJECTION contains TREMELIMUMAB 300MG/15ML, manufactured by ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV). Buy genuine IMJUDO 300MG/15ML INJECTION online at MedZoneAI with fast, reliable delivery across India.

About IMJUDO 300MG/15ML INJECTION

Imjudo 300MG/15ML Injection contains tremelimumab 300mg/15ml. It removes the CTLA-4 brake on T-cells, given with durvalumab, which is why it is classed as a CTLA-4 inhibitor (immunotherapy). Specialists use it for advanced liver cancer and non-small cell lung cancer, with durvalumab. During treatment expect regular checks such as tests for immune side effects on gut, liver and glands. Made by AstraZeneca; pack size 1 vial. MRP Rs 417,522.64 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.

Disclaimer: This information is for general awareness only and is not a substitute for professional medical advice. Always consult a qualified doctor or pharmacist before using any medicine.